Cargando…

Case Report: Cetuximab and nivolumab use in advanced cutaneous squamous cell carcinoma resistant to chemotherapy

We present the case of a 60-year-old man with unresectable cutaneous squamous cell carcinoma (cSCC) of the sternal area, which was not amenable to radiation therapy (stage III, T3N0M0). The treatment history of this patient is remarkable as the disease had progressed through all lines of conventiona...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sernicola, Alvise, Lampitelli, Salvatore, Marraffa, Federica, Maddalena, Patrizia, Grassi, Sara, Richetta, Antonio Giovanni, Calvieri, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000 Research Limited 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993817/ https://www.ncbi.nlm.nih.gov/pubmed/32047600 http://dx.doi.org/10.12688/f1000research.19149.2

Ejemplares similares

Clinical Remission of Cutaneous Squamous Cell Carcinoma of the Auricle with Cetuximab and Nivolumab
por: Chen, Alessandra, et al.
Publicado: (2018)

Metastases risk in thin cutaneous melanoma: prognostic value of clinical-pathologic characteristics and mutation profile
por: Richetta, Antonio G., et al.
Publicado: (2018)

Editorial: Cutaneous manifestations of systemic disease
por: Sernicola, Alvise, et al.
Publicado: (2023)

How to Deal With Post-viral Cutaneous Eruptions in the Era of Coronavirus Infection
por: Sernicola, Alvise, et al.
Publicado: (2020)

Cutaneous adverse reactions after COVID‐19 vaccines in a cohort of 2740 Italian subjects: An observational study
por: Grieco, Teresa, et al.
Publicado: (2021)

Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment
por: Galbiati, Donata, et al.
Publicado: (2019)

Cutaneous Lymphoma and Antibody-Directed Therapies
por: Sernicola, Alvise, et al.
Publicado: (2023)

A Possible Link between Gut Microbiome Composition and Cardiovascular Comorbidities in Psoriatic Patients
por: Valentini, Virginia, et al.
Publicado: (2022)

Primary Cutaneous B-Cell Lymphomas in Patients With Impaired Immunity
por: Russo, Irene, et al.
Publicado: (2020)

Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
por: Oro-Ayude, Marcos, et al.
Publicado: (2020)

Neoplastic and Autoimmune Comorbidities in Patients with Primary Cutaneous B-Cell Lymphoma
por: Mazzetto, Roberto, et al.
Publicado: (2023)

Cetuximab for Immunotherapy-Refractory/Ineligible Cutaneous Squamous Cell Carcinoma
por: Marin-Acevedo, Julian A., et al.
Publicado: (2023)

Recurrent cutaneous abscesses in two Italian family members
por: Cantisani, Carmen, et al.
Publicado: (2010)

Locally Advanced and Unresectable Cutaneous Squamous Cell Carcinoma: Outcomes of Concurrent Cetuximab and Radiotherapy
por: Samstein, Robert M., et al.
Publicado: (2014)

Avelumab in Combination With Cetuximab and Chemotherapy as First-Line Treatment for Patients With Advanced Squamous NSCLC
por: Andric, Zoran, et al.
Publicado: (2023)

COVID-19 infection and BNT162b2 vaccine triggering sarcoid-like lesions in the same patient. Response to: Sarcoid-like reaction in a patient recovering from COVID-19 pneumonia
por: Grieco, Teresa, et al.
Publicado: (2022)

Cetuximab is efficient and safe in patients with advanced cutaneous squamous cell carcinoma: a retrospective, multicentre study
por: Montaudié, Henri, et al.
Publicado: (2020)

First-line targeted therapies in the treatment of metastatic colorectal cancer – role of cetuximab
por: Tonini, Giuseppe, et al.
Publicado: (2009)

Induction chemotherapy with cetuximab, carboplatin and paclitaxel for the treatment of locally advanced squamous cell carcinoma of the head and neck
por: BAUMAN, JESSICA, et al.
Publicado: (2013)

Paradoxical Psoriasis Induced by Anti-TNFα Treatment: Evaluation of Disease-Specific Clinical and Genetic Markers
por: Bucalo, Agostino, et al.
Publicado: (2020)

Atypical response with bone pseudoprogression in a patient receiving nivolumab for advanced cutaneous squamous cell carcinoma
por: Oliveira, Leandro J. C., et al.
Publicado: (2018)

Case Series: Cemiplimab and Nivolumab Immunotherapy as Promising Treatment in Advanced or Metastatic Cutaneous Squamous Cell Carcinoma
por: Lai, Fei Ya, et al.
Publicado: (2023)

T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinoma
por: Wang, Xuefeng, et al.
Publicado: (2022)

Identification of Novel Dermoscopic Patterns for “Featureless Melanoma”: Clinical-Pathological Correlation
por: Lampitelli, Salvatore, et al.
Publicado: (2023)

Effectiveness and toxicity of cetuximab with concurrent RT in locally advanced cutaneous squamous cell skin cancer: a case series
por: Chang, Mark, et al.
Publicado: (2023)

Effects of dupilumab in type 1 neurofibromatosis coexisting with severe atopic dermatitis()()
por: Chello, Camilla, et al.
Publicado: (2021)

Pneumatosis Cystoides Intestinalis after Cetuximab Chemotherapy for Squamous Cell Carcinoma of Parotid Gland
por: Petrides, Christos, et al.
Publicado: (2015)

Multiple Cutaneous Manifestations in ANCA-Positive Eosinophilic Granulomatosis with Polyangiitis before and after Biologic Therapy: Clinical and Histopathologic Characterization of a Paradigmatic Case
por: Carnicelli, Giorgia, et al.
Publicado: (2022)

Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy
por: Marín-Jiménez, Juan A., et al.
Publicado: (2022)

Folgoration as an Example of Pathergy in a Patient Affected by Pyoderma Gangrenosum and Takayasu's Arteritis
por: Richetta, A. G., et al.
Publicado: (2009)

Cost-Effectiveness of Cetuximab for Advanced Esophageal Squamous Cell Carcinoma
por: Janmaat, Vincent T., et al.
Publicado: (2016)

Nivolumab-associated cutaneous T-cell lymphoma
por: Marks, Jennifer A., et al.
Publicado: (2021)

Role of Rituximab in the Treatment of Pemphigus Vulgaris: Patient Selection and Acceptability
por: Ciolfi, Christian, et al.
Publicado: (2022)

Appearance of malignant melanoma after a non-cutaneous cancer diagnosis
por: Bottoni, Ugo, et al.
Publicado: (2013)

Tomotherapy concomitant with cetuximab, followed by cetuximab as single-agent therapy for unresectable squamous cell carcinoma of the skin: a case report
por: Falivene, Sara, et al.
Publicado: (2014)

Cetuximab Plus Chemotherapy versus Chemotherapy Alone in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Cost-Effectiveness Analysis
por: Lang, Yitian, et al.
Publicado: (2020)

Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II Study
por: Chung, Christine H., et al.
Publicado: (2021)

Fluorescence molecular imaging using cetuximab‐800CW in cutaneous squamous cell carcinoma surgery: a proof‐of‐concept study
por: Vonk, Jasper, et al.
Publicado: (2022)

A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer
por: De Vita, F, et al.
Publicado: (2011)

Biochip detection of BP180 autoantibodies in blister fluid for the serodiagnosis of bullous pemphigoid: A pilot study
por: Sernicola, Alvise, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8gs0472a0bldiurvu8r8m27shb